A089230 Stock Overview
The E&M Co., Ltd. develops and operates platforms based on live streaming technology in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
The E&M Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,040.00 |
| 52 Week High | ₩3,590.00 |
| 52 Week Low | ₩1,500.00 |
| Beta | 1.38 |
| 1 Month Change | 8.17% |
| 3 Month Change | -5.12% |
| 1 Year Change | -30.85% |
| 3 Year Change | -82.93% |
| 5 Year Change | -81.45% |
| Change since IPO | -99.05% |
Recent News & Updates
Shareholder Returns
| A089230 | KR Entertainment | KR Market | |
|---|---|---|---|
| 7D | -4.0% | 0.1% | -2.4% |
| 1Y | -30.8% | -21.8% | 1.9% |
Return vs Industry: A089230 underperformed the KR Entertainment industry which returned -21.8% over the past year.
Return vs Market: A089230 underperformed the KR Market which returned 1.9% over the past year.
Price Volatility
| A089230 volatility | |
|---|---|
| A089230 Average Weekly Movement | 12.1% |
| Entertainment Industry Average Movement | 5.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A089230 has not had significant price volatility in the past 3 months.
Volatility Over Time: A089230's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | n/a | www.theenm.com |
The E&M Co., Ltd. develops and operates platforms based on live streaming technology in South Korea. The company offers POPKON TV, a live streaming-based personal broadcasting platform and POPCAST SOLUTION, a personal broadcasting B2B solution, as well as IC ENTERTAINMENT, which plans and produces optimized content for each creator; CL&COMPANY for actor-centered management services; and LUCA AICELL for the development of a drug delivery system, CTC diagnosis, drug screening platforms, and gene delivery platforms using nanotechnology-based lipid bilayer technology. It is involved in investing, management consulting, and celebrity management up services.
The E&M Co., Ltd. Fundamentals Summary
| A089230 fundamental statistics | |
|---|---|
| Market cap | ₩40.85b |
| Earnings (TTM) | -₩33.57b |
| Revenue (TTM) | ₩31.70b |
1.3x
P/S Ratio-1.2x
P/E RatioIs A089230 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A089230 income statement (TTM) | |
|---|---|
| Revenue | ₩31.70b |
| Cost of Revenue | ₩27.51b |
| Gross Profit | ₩4.19b |
| Other Expenses | ₩37.77b |
| Earnings | -₩33.57b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.68k |
| Gross Margin | 13.23% |
| Net Profit Margin | -105.90% |
| Debt/Equity Ratio | 144.0% |
How did A089230 perform over the long term?
See historical performance and comparison